MiR-182-5p and miR-375-3p Have Higher Performance Than PSA in Discriminating Prostate Cancer from Benign Prostate Hyperplasia

SIMPLE SUMMARY: Prostate cancer (PCa) is the most prevalent neoplasia among men worldwide but is commonly “mimicked” by benign prostate hyperplasia (BPH). Their discrimination by the prostate-specific antigen (PSA) is often uncertain, resulting in lengthy diagnostic protocols and recurrent tissue bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abramovic, Irena, Vrhovec, Borna, Skara, Lucija, Vrtaric, Alen, Nikolac Gabaj, Nora, Kulis, Tomislav, Stimac, Goran, Ljiljak, Dejan, Ruzic, Boris, Kastelan, Zeljko, Kruslin, Bozo, Bulic-Jakus, Floriana, Ulamec, Monika, Katusic-Bojanac, Ana, Sincic, Nino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123314/
https://www.ncbi.nlm.nih.gov/pubmed/33922968
http://dx.doi.org/10.3390/cancers13092068

Ejemplares similares

Ejemplares similares